What must a dermatovenereologist be aware of the infective phenotype of chronic pelvic pain?
- Authors: Kovalyk V.P.1,2, Gomberg M.A.3, Vladimirova E.V.1, Kolieva G.L.3, Yurlov K.I.4, Kusch A.A.4
-
Affiliations:
- Federal Research and Clinical Center for Specialized Types of Medical Care and Medical Technologies, Federal Biomedical Agency of Russia
- Moscow Research and Practical Center for Dermatovenereology and Cosmetology, Moscow City Healthcare Department
- Dermatovenereology and Cosmetology, Moscow City Healthcare Department
- N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of Russia
- Issue: Vol 34, No 7 (2023)
- Pages: 18-21
- Section: For Diagnosis
- URL: https://journals.eco-vector.com/0236-3054/article/view/567984
- DOI: https://doi.org/10.29296/25877305-2023-07-03
- ID: 567984
Cite item
Abstract
Changing the paradigm has led to the gradual replacement of the concept “chronic prostatitis in the scientific literature with the generally accepted one “chronic pelvic pain syndrome (CPPS), which could be the reason for misunderstanding between the physicians of different specialties. The review gives information about the role of individual sexually transmitted infections in the etiology of CPPS. According to the present views, in addition to prostatic diseases, the pattern of this syndrome can embrace gastrointestinal tract diseases, neurological and infectious diseases.
Along with opportunistic mycoplasmas, sexually transmitted infections should be taken into account when managing males with chronic prostatitis/CPPS. The detection of these microorganisms requires the prescription of antibacterial therapy.
Full Text
About the authors
V. P. Kovalyk
Federal Research and Clinical Center for Specialized Types of Medical Care and Medical Technologies, Federal Biomedical Agency of Russia; Moscow Research and Practical Center for Dermatovenereology and Cosmetology, Moscow City Healthcare Department
Author for correspondence.
Email: kovalyk@mail.ru
ORCID iD: 0000-0002-0453-2771
Candidate of Medical Sciences, Associate Professor
Russian Federation, Moscow; MoscowM. A. Gomberg
Dermatovenereology and Cosmetology, Moscow City Healthcare Department
Email: kovalyk@mail.ru
ORCID iD: 0000-0002-1070-5229
Doctor of Medical Sciences, Professor
Russian Federation, MoscowE. V. Vladimirova
Federal Research and Clinical Center for Specialized Types of Medical Care and Medical Technologies, Federal Biomedical Agency of Russia
Email: kovalyk@mail.ru
ORCID iD: 0000-0002-4123-4204
Candidate of Medical Sciences, Associate Professor
Russian Federation, MoscowG. L. Kolieva
Dermatovenereology and Cosmetology, Moscow City Healthcare Department
Email: kovalyk@mail.ru
ORCID iD: 0009-0007-1452-5659
Candidate of Medical Sciences
Russian Federation, MoscowK. I. Yurlov
N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of Russia
Email: kovalyk@mail.ru
ORCID iD: 0000-0002-4694-2445
Russian Federation, Moscow
A. A. Kusch
N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of Russia
Email: kovalyk@mail.ru
ORCID iD: 0000-0002-3396-5533
Doctor of Medical Sciences, Professor
Russian Federation, MoscowReferences
- Magri V., Boltri M., Cai T. et al. Multidisciplinary approach to prostatitis. Arch Ital Urol Androl. 2019; 90 (4): 227–48. doi: 10.4081/aiua.2018.4.227
- Bryk D.J., Shoskes D.A. Using the UPOINT system to manage men with chronic pelvic pain syndrome. Arab J Urol. 2021; 19 (3): 387–93. doi: 10.1080/2090598X.2021.1955546
- Zhao Z., Zhang J., He J. et al. Clinical Utility of the UPOINT Phenotype System in Chinese Males with Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS): a Prospective Study. PLoS One. 2013; 8 (1): e52044. doi: 10.1371/journal.pone.0052044
- Arda E., Cakiroglu B., Tas T. et al. Use of the UPOINT Classification in Turkish Chronic Prostatitis or Chronic Pelvic Pain Syndrome Patients. Urology. 2016; 97: 227–31. doi: 10.1016/j.urology.2016.07.023
- Lian W.Q., Luo F., Song X.L. et al. Gonorrhea and Prostate Cancer Incidence: An Updated Meta-Analysis of 21 Epidemiologic Studies. Med Sci Monit. 2015; 21: 1895–903. doi: 10.12659/MSM.893579
- Whelan J., Eeuwijk J., Bunge E. et al. Systematic Literature Review and Quantitative Analysis of Health Problems Associated with Sexually Transmitted Neisseria gonorrhoeae Infection. Infect Dis Ther. 2021; 10 (4): 1887–905. doi: 10.1007/s40121-021-00481-z
- Pust R. et al. Klinische und experimentelle Urologie 11. Weidner W., Brunner H., Krause W., Rothauge CF (eds) Therapy of prostatitis. Munich: Zuckschwerdt, 1986; рp. 102–9.
- Молочков В.А., Ильин И.И. Хронический уретрогенный простатит. М.: Медицина, 1998; 304 с. [Molochkov V.A., Il'in I.I. Khronicheskii uretrogennyi prostatit. M.: Meditsina, 1998; 304 р. (in Russ.)].
- Abdelatif O.M., Chandler F.W. McGuire B.S. Jr. Chlamydia trachomatis in chronic abacterial prostatitis: demonstration by colorimetric in situ hybridization. Hum Pathol. 1991; 22 (1): 41–4. doi: 10.1016/0046-8177(91)90059-x
- Kadar A., Bucsek M., Kardos M. et al. Detection of Chlamydia trachomatis in chronic prostatitis by in situ hybridization (preliminary methodical report). Orv Hetil. 1995; 136 (13): 659–62.
- Funahashi Y., Majima T., Matsukawa Y. et al. Intraprostatic Reflux of Urine Induces Inflammation in a Rat. Prostate. 2017; 77 (2): 164–72. doi: 10.1002/pros.23257
- Koroku M., Kumamoto Y., Hirose T. A study of the role of Chlamydia trachomatis in chronic prostatitis--analysis of anti-Chlamydia trachomatis specific IgA in expressed prostate secretion by western-blotting method. Kansenshogaku Zasshi. 1995; 69: 426–37. doi: 10.11150/kansenshogakuzasshi1970.69.426
- Park H., Sim S.M., Lee G. The presence of Chlamydia is associated with increased leukocyte counts and pain severity in men with chronic pelvic pain syndrome. Urology. 2015; 85 (3): 574–9. doi: 10.1016/j.urology.2014.11.008
- Horner P., Donders G., Cusini M. et al. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? - a position statement from the European STI Guidelines Editorial Board. J Eur Acad Dermatol Venereol. 2018; 32: 1844–51. doi: 10.1111/jdv.15146
- Magri V., Perletti G., Stamatiou K. et al. Lithogenic Potential of Ureaplasma in Chronic Prostatitis. Urol Int. 2021; 105 (3-4): 328–33. doi: 10.1159/000511653
- Shoskes D. UPOINT System for the Clinical Phenotyping of Chronic Pelvic Pain. (Chronic Prostatitis/Chronic Pelvic Pain Syndrome, Interstitial Cystitis, Painfull Bladder Syndrome) 2009. URL: http://www.upointmd.com/
- Shoskes D.A., Nickel J.C., Kattan M.W. Phenotypically Directed Multimodal Therapy for Chronic Prostatitis/Chronic Pelvic Pain Syndrome: a Prospective Study Using UPOINT. Urology. 2010; 75 (6): 1249–53. doi: 10.1016/j.urology.2010.01.021
- Вершинский Б.В. О патогенности Trichomonas vaginalis Donne, 1836. Акушерство и гинекология (Москва). 1958; 34 (4): 76–80 [Vershinskii B.V. Pathogenicity of Trichomonas vaginalis Donne, 1836. Akush Ginekol (Mosk). 1958; 34 (4): 76–80 (in Russ.)].
- Chang P.C., Hsieh M.L., Huang S.T. et al. Detection of Trichomonas vaginalis Infection in Chronic Prostatitis/Chronic Pelvic Pain Syndrome Patients by Rapid Immunochromatographic Test. Pol J Microbiol. 2022; 71 (3): 301–7. doi: 10.33073/pjm-2022-027
- Han I.H., Kim J.H., Kim S.S. et al. Signalling pathways associated with IL-6 production and epithelial-mesenchymal transition induction in prostate epithelial cells stimulated with Trichomonas vaginalis. Parasite Immunol. 2016; 38 (11): 678–87. doi: 10.1111/pim.12357
- Vickovic N., Skerk V., Granic J. et al. Metronidazole 1.5 gram dose for 7 or 14 days in the treatment of patients with chronic prostatitis caused by Trichomonas vaginalis: A randomized study. J Chemother. 2010; 22 (5): 364–5. doi: 10.1179/joc.2010.22.5.364
- Stassen L., Armitage C.W., van der Heide D.J. et al. Zika Virus in the Male Reproductive Tract. Viruses. 2018; 10 (4): 198. doi: 10.3390/v10040198
- Tan S.K., Cheng X.S., Kao C.S. et al. Native kidney cytomegalovirus nephritis and cytomegalovirus prostatitis in a kidney transplant recipient. Transpl Infect Dis. 2019; 21 (1): e12998. doi: 10.1111/tid.12998
- Benson P.J., Smith C.S. Cytomegalovirus prostatitis. Urology. 1992; 40 (2): 165–7. doi: 10.1016/0090-4295(92)90520-7
- Kaspersen M.D., Höllsberg P. Seminal shedding of human herpesviruses. Virol J. 2013; 10: 226. doi: 10.1186/1743-422X-10-226
- Xiao J., Ren L., Lv H. et al. Atypical microorganisms in expressed prostatic secretion from patients with chronic prostatitis/chronic pelvic pain syndrome: microbiological results from a case-control study. Urol Int. 2013; 91 (4): 410–6. doi: 10.1159/000350934
- Ковалык В.П., Гомберг М.А., Юрлов К.И. и др. Хронический простатит, ассоциированный с герпесвирусами: диагностика и эффективность противовирусной терапии. Клиническая дерматология и венерология. 2021; 20 (6): 60–5 [Kovalyk V.P., Gomberg M.A., Yurlov K.I. et al. Chronic prostatitis associated with herpesviruses: diagnosis and efficacy of antiviral therapy. Klinicheskaya Dermatologiya i Venerologiya. 2021; 20 (6): 60–5 (in Russ.)]. doi: 10.17116/klinderma20212006160